| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |